---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-013067"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T07:27:23.965563+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IRADIMED reports record Q2 revenue of $16.1M, raises FY2023 guidance

## Summary
- Q2 revenue $16.1M (+25% YoY); GAAP diluted EPS $0.33 vs $0.26; non-GAAP EPS $0.36 vs $0.26.
- Operating income $5.0M, up 19% YoY; 8th consecutive record revenue quarter.
- Monitoring devices revenue grew 25% YoY to $6.1M; IV pump systems up 17% to $4.5M.
- FY2023 guidance raised: rev $64.5-$65.5M, GAAP EPS $1.25-$1.28, non-GAAP EPS $1.37-$1.40.
- Q3 2023 guidance: rev $16.1-$16.3M, GAAP EPS $0.33-$0.35, non-GAAP EPS $0.36-$0.38.

## SEC filing metadata
- accession: 0001558370-23-013067
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/0001558370-23-013067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/irmd-20230803x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-013067
- JSON: https://secwatch.observer/filing/0001558370-23-013067.json
- Plain text: https://secwatch.observer/filing/0001558370-23-013067.txt

## Key facts
- Earnings Releases
  IRADIMED CORP reported second quarter ended June 30, 2023 results: revenue $16.1 million, net income $4.2 million, EPS $0.33 per diluted share. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $16.1 million
  - Net income: $4.2 million
  - EPS: $0.33 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: For the second quarter ended June 30, 2023, the Company reported over 25% year-over-year revenue growth to $16.1 million compared to $12.7 million for the second quarter of 2022. Net income was $4.2 million, or $0.33 per diluted share, compared to $3.2 million, or $0.26 per diluted share for the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1325618/000155837023013067/0001558370-23-013067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.